Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

PhaseBio Pharmaceuticals (PHAS)

PhaseBio Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PHAS
DateTimeSourceHeadlineSymbolCompany
30/05/202321:03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
19/05/202321:19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
19/05/202321:19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
19/05/202321:17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
19/05/202321:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
16/05/202321:23Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
03/04/202321:06Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
24/03/202312:08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
14/02/202322:07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
14/02/202320:01Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
14/02/202319:27Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
23/12/202213:34Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
21/12/202211:10Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
02/12/202221:20Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
15/11/202221:21Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
04/11/202220:44Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
31/10/202221:22Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
26/10/202221:42Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
24/10/202213:00Business WirePhaseBio Plans for Near-Term Sale Using Structured Process Through Chapter 11 of U.S. Bankruptcy CodeNASDAQ:PHASPhaseBio Pharmaceuticals Inc
07/10/202222:22Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
28/09/202217:05TipRanksPhasebio Pharmaceuticals (PHAS) was downgraded to a Hold Rating at NeedhamNASDAQ:PHASPhaseBio Pharmaceuticals Inc
27/09/202222:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
15/08/202211:15TipRanksH.C. Wainwright Keeps Their Buy Rating on Phasebio Pharmaceuticals (PHAS)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
12/08/202221:15TipRanksPhasebio Pharmaceuticals (PHAS) Receives a Buy from NeedhamNASDAQ:PHASPhaseBio Pharmaceuticals Inc
12/08/202213:34Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
12/08/202213:30Business WirePhaseBio Pharmaceuticals Reports Second Quarter 2022 Financial Results and Recent Business HighlightsNASDAQ:PHASPhaseBio Pharmaceuticals Inc
05/07/202221:32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
16/06/202213:18TipRanks10 Penny Stocks that Could Deliver Exponential ReturnsNASDAQ:PHASPhaseBio Pharmaceuticals Inc
24/05/202222:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
24/05/202222:14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:PHAS